ESMO Copenhagen 2016: a lung cancer ‘grand cru’
نویسنده
چکیده
منابع مشابه
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up M. Sørensen, M. Pijls-Johannesma & E. Felip On behalf of the ESMO Guidelines Working Group* Department of Oncology, The Finsen Centre, Copenhagen, Denmark; Department of Radiation Oncology, MAASTRO Clinic, GROW Research Institute, Maastricht University Medical Center, Maastricht, The Netherlands; Me...
متن کاملRecent Developments in Regorafenib Treatment for Gastrointestinal Cancers: Presentations at the European Society for Medical Oncology (esmo) Congress 2016
The European Society for Medical Oncology (ESMO) Congress was held in Copenhagen, Denmark from 7th–11th October 2016. The use of the promiscuous multikinase inhibitor regorafenib (Stivarga®, BAY 73-4506) in the treatment of cancers of the gastrointestinal (GI) tract was strongly featured at this meeting. Regorafenib targets multiple kinases involved in oncogenesis and angiogenesis, and is US Fo...
متن کاملCancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
K. Fizazi1, F. A. Greco2, N. Pavlidis3, G. Daugaard4, K. Oien5 & G. Pentheroudakis3, on behalf of the ESMO Guidelines Committee* Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Tennessee Oncology, Centennial Medical Center, Nashville, USA; Department of Medical Oncology, University of Ioannina, Ioannina, Greece; Department of Oncology 5073, Ri...
متن کاملState-of-the-art Integration of Multiple Kinase Inhibitors in the Treatment of Gastrointestinal Cancers
Oral multikinase inhibitors have the potential to improve outcomes for patients with a variety of malignancies, such as colorectal cancer, gastric cancer, HCC, and sarcomas, including GISTs. However, many oncologists remain unfamiliar with multikinase inhibitors and their role in treating gastrointestinal tumours, despite >2 years of STATE-OF-THE-ART INTEGRATION OF MULTIPLE KINASE INHIBITORS IN...
متن کاملESMO Women for Oncology 2016: a very personal tale of my professional life in Asia
In Thailand, 30 years ago, when I started my career as the first medical oncologist at the Faculty of Medicine, Chiang Mai University, cancer was considered to be an incurable disease and treatment with chemotherapy was generally considered ineffective. In the Department of Medicine, the only cancers that received chemotherapy were the haematological malignancies, and these were treated by haem...
متن کامل